Pathogenesis of Nonalcoholic Steatohepatitis

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2016 Mar 2

PMID 26928243

Citations 227

Authors

Mariana Verdelho Machado

Anna Mae Diehl

Affiliations

Soon will be listed here.

Abstract

Nonalcoholic steatohepatitis (NASH) is a necro-inflammatory response that ensues when hepatocytes are injured by lipids (lipotoxicity). NASH is a potential outcome of nonalcoholic fatty liver (NAFL), a condition that occurs when lipids accumulate in hepatocytes. NASH may be reversible, but it can also result in cirrhosis and primary liver cancer. We are beginning to learn about the mechanisms of progression of NAFL and NASH. NAFL does not inevitably lead to NASH because NAFL is a heterogeneous condition. This heterogeneity exists because different types of lipids with different cytotoxic potential accumulate in the NAFL, and individuals with NAFL differ in their ability to defend against lipotoxicity. There are no tests that reliably predict which patients with NAFL will develop lipotoxicity. However, NASH encompasses the spectrum of wound-healing responses induced by lipotoxic hepatocytes. Differences in these wound-healing responses among individuals determine whether lipotoxic livers regenerate, leading to stabilization or resolution of NASH, or develop progressive scarring, cirrhosis, and possibly liver cancer. We review concepts that are central to the pathogenesis of NASH.

Citing Articles

Reactive Dicarbonyl Scavenging with 2-Hydroxybenzylamine Improves MASH.

Cheung-Flynn J, Rathmacher J, Pitchford L, Xiong Y, Flynn C Nutrients. 2025; 17(4).

PMID: 40004939 PMC: 11858443. DOI: 10.3390/nu17040610.

Therapeutic Actions of Hepatocyte Extracellular Vesicles in a Murine Model of Diet-Induced Steatohepatitis with Fibrosis.

Li X, Chen R, Kemper S, Xu Z, Brigstock D Biomedicines. 2025; 13(2).

PMID: 40002688 PMC: 11852249. DOI: 10.3390/biomedicines13020274.

Clinical Assessment of Common Medications for Nonalcoholic Fatty Liver Disease: A Systematic Review and Bayesian Network Meta-Analysis.

Shi R, Chai K, Wang H, Zhou J, Yang S, Li J J Evid Based Med. 2025; 18(1):e70002.

PMID: 39963857 PMC: 11833758. DOI: 10.1111/jebm.70002.

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017-2020.

Yang B, Gong M, Zhu X, Luo Y, Li R, Meng H Front Endocrinol (Lausanne). 2025; 16:1514093.

PMID: 39959621 PMC: 11825334. DOI: 10.3389/fendo.2025.1514093.

Water-Soluble Cellulose Acetate Changes the Intestinal Microbiota in Mice with Non-Alcoholic Steatohepatitis.

Iida A, Takahashi E, Kuranuki S, Shimamoto S, Nakamura T, Kitagaki H Nutrients. 2025; 17(3).

PMID: 39940357 PMC: 11820315. DOI: 10.3390/nu17030500.

References

Nojima H, Freeman C, Schuster R, Japtok L, Kleuser B, Edwards M . Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J Hepatol. 2015; 64(1):60-8. PMC: 4843792. DOI: 10.1016/j.jhep.2015.07.030. View

Xie G, Karaca G, Swiderska-Syn M, Michelotti G, Kruger L, Chen Y . Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. Hepatology. 2013; 58(5):1801-13. PMC: 3758784. DOI: 10.1002/hep.26511. View

Guy C, Suzuki A, Zdanowicz M, Abdelmalek M, Burchette J, Unalp A . Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology. 2012; 55(6):1711-21. PMC: 3499103. DOI: 10.1002/hep.25559. View

Rangwala F, Guy C, Lu J, Suzuki A, Burchette J, Abdelmalek M . Increased production of sonic hedgehog by ballooned hepatocytes. J Pathol. 2011; 224(3):401-10. PMC: 3628812. DOI: 10.1002/path.2888. View

Ding B, Cao Z, Lis R, Nolan D, Guo P, Simons M . Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature. 2013; 505(7481):97-102. PMC: 4142699. DOI: 10.1038/nature12681. View

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal W, Strowig T . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482(7384):179-85. PMC: 3276682. DOI: 10.1038/nature10809. View

Donnelly K, Smith C, Schwarzenberg S, Jessurun J, Boldt M, Parks E . Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005; 115(5):1343-51. PMC: 1087172. DOI: 10.1172/JCI23621. View

Choi S, Omenetti A, Witek R, Moylan C, Syn W, Jung Y . Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2009; 297(6):G1093-106. PMC: 2850083. DOI: 10.1152/ajpgi.00292.2009. View

Musso G, Gambino R, Cassader M, Pagano G . Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2010; 43(8):617-49. DOI: 10.3109/07853890.2010.518623. View

10.

Filozof C, Goldstein B, Williams R, Sanyal A . Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. Drugs. 2015; 75(12):1373-92. PMC: 4532706. DOI: 10.1007/s40265-015-0437-3. View

11.

Cusi K . Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology. 2012; 142(4):711-725.e6. DOI: 10.1053/j.gastro.2012.02.003. View

12.

Sicklick J, Li Y, Melhem A, Schmelzer E, Zdanowicz M, Huang J . Hedgehog signaling maintains resident hepatic progenitors throughout life. Am J Physiol Gastrointest Liver Physiol. 2005; 290(5):G859-70. DOI: 10.1152/ajpgi.00456.2005. View

13.

Yamaguchi K, Yang L, McCall S, Huang J, Yu X, Pandey S . Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007; 45(6):1366-74. DOI: 10.1002/hep.21655. View

14.

Cortez-Pinto H, Chatham J, Chacko V, Arnold C, Rashid A, Diehl A . Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 1999; 282(17):1659-64. DOI: 10.1001/jama.282.17.1659. View

15.

Michelotti G, Xie G, Swiderska M, Choi S, Karaca G, Kruger L . Smoothened is a master regulator of adult liver repair. J Clin Invest. 2013; 123(6):2380-94. PMC: 3668809. DOI: 10.1172/JCI66904. View

16.

Swiderska-Syn M, Syn W, Xie G, Kruger L, Machado M, Karaca G . Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut. 2013; 63(8):1333-44. PMC: 4006344. DOI: 10.1136/gutjnl-2013-305962. View

17.

Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G . Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology. 1999; 29(6):1743-51. DOI: 10.1002/hep.510290632. View

18.

Bays H . Adiposopathy, "sick fat," Ockham's razor, and resolution of the obesity paradox. Curr Atheroscler Rep. 2014; 16(5):409. PMC: 3972445. DOI: 10.1007/s11883-014-0409-1. View

19.

Verma V, Li H, Wang R, Hirsova P, Mushref M, Liu Y . Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol. 2015; 64(3):651-60. PMC: 4761285. DOI: 10.1016/j.jhep.2015.11.020. View

20.

Begriche K, Massart J, Robin M, Bonnet F, Fromenty B . Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology. 2013; 58(4):1497-507. DOI: 10.1002/hep.26226. View